Abstract: Objective To investigate the safety，feasibility and clinical application value of the robotic-assisted gynecological surgery in the treatment of cervical cancer. Methods A retrospective analysis was made on the clinical data of 75 cases of cervical cancer who undergoing radical hysterectomy at General Hospital of the Second Artillery between March 2010 and February 2014， including 23 cases of cervical cancer undergoing robotic radical hysterectomy（RRH）, 15 cases of cervical cancer undergoing laparoscopic radical hysterectomy（LRH） and 37 cases of cervical cancer undergoing abdominal radical hysterectomy（ARH）. Results The operation blood loss was（110.6±31.0）ml，（274.2±44.6）ml and（1219.0±738.7）ml; volume of blood transfusion was（17±100）ml，（80±160）ml and（1000±560）ml; operative complications was 8.6％， 20.0％ and 48.6％ and postoperative anal exhaust time was（33.2±17.0）h，（51.0±10.8）h and（63.7±7.9）h in RRH， LRH and ARH group， respectively. The differences of the above indexes in RRH group was of statistical significance compared with LRH and ARH group（P＜0.05）. Conclusion Robotic-assisted gynecological surgery in the treatment of cervical cancer is safe and feasible compared with laparoscopy and open abdomen operation. It has certain clinical application value because of its advantages such as less operation blood loss and operative complications and shorter postoperative anal exhaust time.